GLP‐1 Agonists as Potential Neuromodulators in Development of Parkinson’s Disease: A Nationwide Cohort Study
Background Parkinson’s disease is a progressive neurodegenerative disorder with no cure. Glucagon-like peptide-1 receptor agonists (GLP-1RAs) may have neuroprotective effects. However, long-term rea…